Trial of AVN-944 in Patients With Advanced Hematologic Malignancies

Clinical trial NCT00273936 · COMPLETED

Trial details

NCT number: NCT00273936
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Leukemia Chronic Leukemia Multiple Myeloma Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Waldenstrom's Macroglobulinemia

Start date: 2006-01-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.